A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume 13, Issue 8, Pages 1345-1350
Publisher
American Chemical Society (ACS)
Online
2022-07-19
DOI
10.1021/acsmedchemlett.2c00260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Nitrile Peptidomimetics for Treating COVID-19
- (2022) C. S. Brian Chia ACS Medicinal Chemistry Letters
- Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
- (2021) Cheng Liu et al. ANTIVIRAL RESEARCH
- A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
- (2021) Subramanyam Vankadara et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
- (2021) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A tale of two antiviral targets — and the COVID-19 drugs that bind them
- (2021) Megan Cully NATURE REVIEWS DRUG DISCOVERY
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients
- (2020) Christian Gampe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potential SARS-CoV-2 main protease inhibitors
- (2020) Riddhidev Banerjee et al. DRUG DISCOVERY TODAY
- Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery
- (2019) Nenad Manevski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors
- (2018) Wint Wint Phoo et al. ANTIVIRAL RESEARCH
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease
- (2016) Yong Wah Tan et al. Scientific Reports
- Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2–P4 study
- (2015) Melgious J. Y. Ang et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease
- (2015) Yangyang Zhai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: A P1–P4 SAR study
- (2013) Melgious Jin Yan Ang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: A P3 and N-cap optimization study
- (2013) Huichang Annie Lim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel therapies for hepatitis C — one pill fits all?
- (2013) Michael P. Manns et al. NATURE REVIEWS DRUG DISCOVERY
- Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
- (2012) Chi-Pang Chuck et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started